CC-930 (Tanzisertib)
Catalog No. A13564
CC-930在蛋白底物c-Jun的JNK依赖性磷酸化中与ATP动力学竞争，并且对JNK的所有同工型均有效（Ki（JNK1）= 44±3 nM，IC50（JNK1）= 61 nM，Ki（JNK2 ）= 6.2±0.6 nM，IC50（JNK2）= 5 nM，IC50（JNK3）= 5 nM），对MAP激酶ERK1和p38a具有选择性，IC50分别为0.48和3.4μM。
| Catalog Num | A13564 |
|---|---|
| M. Wt | 448.44 |
| Formula | C21H23F3N6O2 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 899805-25-5 |
| Synonyms | Tanzisertib, CC 930, CC930 |
| SMILES | C1COC[C@H]1N2C3=NC(=NC=C3N=C2NC4=C(C=C(C=C4F)F)F)NC5CCC(CC5)O |
CC-930在蛋白底物c-Jun的JNK依赖性磷酸化中与ATP动力学竞争，并且对JNK的所有同工型均有效（Ki（JNK1）= 44±3 nM，IC50（JNK1）= 61 nM，Ki（JNK2 ）= 6.2±0.6 nM，IC50（JNK2）= 5 nM，IC50（JNK3）= 5 nM），对MAP激酶ERK1和p38a具有选择性，IC50分别为0.48和3.4μM。
| In vitro | DMSO | Warmed: 80 mg/mL (164.98 mM) | |
| Water | Warmed: 4 mg/mL (8.24 mM) | ||
| Ethanol | Warmed: 80 mg/mL (164.98 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.3 mL | 111.5 mL | 223 mL |
| 0.5 mM | 4.46 mL | 22.3 mL | 44.6 mL |
| 1 mM | 2.23 mL | 11.15 mL | 22.3 mL |
| 5 mM | 0.45 mL | 2.23 mL | 4.46 mL |
*The above data is based on the productmolecular weight 448.44. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.